Daily Cosmetic Research Analysis
Analyzed 5 papers and selected 3 impactful papers.
Summary
Methodological and clinical advances in cosmetic-related care emerged today: an updated aggregate exposure model for fragrance ingredients improves realism by integrating newer habits-and-practices data and homecare products; a pediatric cohort shows tissue adhesive quadruples the risk of dynamic expression dimpling versus layered suturing, while postoperative laser improves scar scores; and a minimally invasive yellow laser technique safely treats deep conjunctival nevi with preserved ocular surface health.
Research Themes
- Cosmetics safety and exposure modeling
- Aesthetic wound closure strategies in pediatrics
- Minimally invasive oculoplastic laser therapy
Selected Articles
1. Integrating new habits and practices data and homecare products into the Creme RIFM Aggregate Exposure Model.
This methodological paper updates the Creme RIFM aggregate exposure model by replacing 2007–2008 habits-and-practices data with 2014–2015 surveys, adding more products, countries, and age groups, and incorporating household care products. The work enhances realism of exposure factor inputs and provides comparative analyses between legacy and updated models.
Impact: Improved exposure inputs for fragrance safety assessment can materially influence risk characterization and regulatory decisions for cosmetics and homecare products.
Clinical Implications: While indirect to clinical care, more realistic exposure assessments can refine safety margins, inform ingredient concentration limits, and ultimately reduce adverse reactions in consumers, especially vulnerable age groups.
Key Findings
- Phase III replaced 2007–2008 Kantar habits-and-practices data with 2014–2015 surveys for the same product set.
- The model expanded to include additional products, more countries, and broader age groups.
- Household care products were newly integrated, enabling aggregate exposure estimates across cosmetics, personal, air, and household care.
- Comparisons between old and new exposure factor inputs are presented to quantify the impact of updated data.
Methodological Strengths
- Integration of manufacturer concentration data with large-scale consumer habits-and-practices surveys
- Dynamic model architecture enabling iterative updates and cross-model comparisons
Limitations
- Potential industry data bias and limited transparency on uncertainty quantification
- Lack of external validation against biomonitoring datasets within this manuscript
Future Directions: Incorporate biomonitoring for validation, extend to emerging product categories and geographies, and enhance openness of data, code, and uncertainty analyses.
The Research Institute for Fragrance Materials (RIFM) and Creme Global, in collaboration with fragrance and consumer products industries, have developed an aggregate exposure model for fragrance ingredients in cosmetics, personal care, and air care products. At the core of this model is product concentration data provided by manufacturers (fragrance suppliers and consumer product companies) and habits and practices survey data collected by Kantar Worldpanel. The model is dynamic and flexible, allowing for updates based on new data and evolving science, with several updates released since its inception. In the most recent phase of model development (Phase III), the 2007-2008 Kantar Worldpanel survey data have been updated, replacing them with habits and practices survey data collected in 2014 and 2015 for the same products acquired during the Phase I and Phase II updates to the model. In addition to replacing existing data, the new survey includes data on additional products, countries, and expanded age groups. The list of products in the model was also expanded to include several household care products. This manuscript summarizes the new data and presents comparisons between the exposure factor inputs for the new and old models.
2. Outcomes of cosmetic suturing versus tissue adhesive for pediatric forehead lacerations: A retrospective cohort study adjusting for injury severity.
In a severity-adjusted retrospective cohort of 265 pediatric forehead lacerations, tissue adhesive produced a higher rate of dynamic expression dimpling versus layered suturing (11.5% vs 3.0%), and remained an independent risk after propensity matching (OR 3.92). Twelve-month Vancouver Scar Scale scores were driven by initial wound depth and postoperative laser therapy, not closure method.
Impact: Findings challenge routine reliance on tissue adhesive for cosmetically sensitive pediatric forehead wounds by quantifying functional contour deformity risk and identifying postoperative laser as an independent scar-optimizing factor.
Clinical Implications: For deeper pediatric forehead lacerations, layered cosmetic suturing should be preferred to minimize dynamic dimpling; tissue adhesive use should be limited to superficial wounds with counseling about contour risks. Early postoperative laser therapy can be considered to improve long-term scar quality.
Key Findings
- Tissue adhesive was associated with higher dynamic expression dimpling than suturing (11.5% vs 3.0%, P=0.007).
- After propensity score matching, tissue adhesive remained an independent risk factor for dimpling (OR=3.92, P=0.029).
- Twelve-month Vancouver Scar Scale scores were predicted by initial wound depth (β=0.312, P<0.001) and postoperative laser therapy (β=-0.205, P=0.001), not closure method (P=0.345).
- Significant selection bias existed: the suture group had deeper and longer wounds, yet still had less dimpling.
Methodological Strengths
- Propensity score matching and multivariable regression to adjust for baseline severity
- Post-hoc power analysis supporting sample adequacy and 12-month follow-up for scar outcomes
Limitations
- Retrospective single-period design with potential residual confounding and selection bias
- Non-randomized treatment allocation and lack of blinded outcome assessment reported
Future Directions: Prospective randomized trials stratified by wound depth are needed; include blinded cosmetic assessments, patient-reported outcomes, and cost-effectiveness; refine criteria for when adhesives are safe.
PURPOSE: To compare the clinical outcomes of cosmetic layered suturing versus medical tissue adhesive in pediatric forehead lacerations, with specific emphasis on the risk of dynamic expression dimpling and long-term scar quality, after adjusting for baseline wound severity. METHODS: A retrospective cohort study was conducted on 265 pediatric patients with acute forehead trauma treated between October 2023 and May 2024. Patients were stratified into a Cosmetic Suture Group (n=135) and Tissue Adhesive Group (n=130). A post-hoc power analysis confirmed sample adequacy. Baseline characteristics were analyzed to identify selection bias. The primary outcomes were the incidence of dynamic expression dimpling and 12-month Vancouver Scar Scale (VSS) score. Multivariable regression and sensitivity analyses using propensity score matching (PSM) were performed. RESULTS: Significant selection bias was observed: the Suture Group managed wounds that were significantly deeper (P<0.001) and longer (P<0.001). Despite treating less severe injuries, the Adhesive Group exhibited a significantly higher incidence of postoperative dynamic expression dimpling (11.5% vs. 3.0%, P=0.007). Sensitivity analysis via PSM confirmed that tissue adhesive was an independent risk factor for expression dimpling (OR=3.92, P=0.029). Regarding long-term scar appearance, linear regression revealed that 12-month VSS scores were predicted by initial wound depth (β=0.312, P<0.001) and the use of postoperative laser therapy (β=-0.205, P=0.001), rather than the closure method itself (P=0.345). CONCLUSION: Although tissue adhesives offer procedural convenience, they are associated with a quadrupled risk of dynamic expression dimpling compared to suturing, likely owing to inadequate approximation of the underlying frontalis muscle. Layered cosmetic suturing is essential for preventing contour deformities in deep lacerations. Furthermore, postoperative laser therapy is a validated independent factor for optimizing scar outcomes.
3. Yellow Laser Photocoagulation of Deep Conjunctival Nevus: A Minimally Invasive Technique.
In a prospective interventional case series of 10 eyes, 577 nm yellow laser photocoagulation achieved high lesion resolution (85% when fully applied) without significant changes in ocular surface parameters and no recurrences over a mean 10.5-month follow-up. A single scarring event occurred due to inadvertent Tenon’s application.
Impact: Provides a minimally invasive, office-based alternative for cosmetically significant conjunctival nevi, maintaining ocular surface health and demonstrating promising efficacy.
Clinical Implications: Yellow 577 nm laser photocoagulation can be considered for deep, pigmented conjunctival nevi as an outpatient procedure with favorable cosmetic outcomes; surgeons should avoid Tenon’s capsule to prevent scarring.
Key Findings
- Prospective series of 10 eyes showed 85% complete resolution when laser was fully applied, with no recurrences over a mean 10.5 months.
- No significant changes were detected in Schirmer test, Oxford staining, OSDI, tear meniscus height, or NIKBUT.
- 90% of eyes required a single session; one eye needed a second due to lesion size.
- One complication occurred: conjunctival scarring from inadvertent Tenon’s capsule application.
Methodological Strengths
- Prospective design with predefined laser parameters and structured follow-up time points
- Objective assessments of ocular surface health (Schirmer, Oxford score, OSDI, NIKBUT) and imaging confirmation with anterior segment OCT
Limitations
- Small, non-comparative case series limits generalizability and effect size precision
- Short-to-moderate follow-up; operator-dependent technique with learning curve
Future Directions: Conduct controlled comparative studies against excision or other laser modalities, extend follow-up, and include patient-reported cosmetic outcomes and cost analyses.
PurposeTo evaluate the safety and efficacy of yellow laser photocoagulation for deep conjunctival nevi.MethodologyThis prospective interventional case series included patients with clinically stable conjunctival nevi for ≥6 months. Treatment was performed using the Iridex yellow laser (577 nm) under topical anesthesia, with a 200-micron spot, 80 ms exposure, and 300-600 mW power. The lesion was removed with sterile cotton buds post-laser, and topical steroids were prescribed for one week. Follow-up was at day 1, week 1, month 1, and month 3, assessing ocular surface health and lesion resolution. Examinations included Schirmer Test 1, Oxford corneal staining, Ocular Surface Disease Index (OSDI), tear meniscus height, and non-invasive keratograph break-up time (NIKBUT).ResultsThe study included 10 eyes from 9 patients. Mean age was 30 years (range: 6-63), with a 1:1 sex ratio. Anterior segment OCT confirmed subepithelial lesions in all, with intralesional cysts in 60%. Mean nevus diameter was 4.2 mm (range: 2-11), and 70% showed severe pigmentation. Laser treatment was completed in one session for 90% of eyes; one required a second due to large size. No significant changes were observed in ocular surface parameters. At a mean follow-up of 10.5 months (range: 3-17), 85% (6/7) of eyes had complete resolution when the laser was fully applied. No recurrence occurred. One patient developed conjunctival scarring from inadvertent Tenon's capsule application.ConclusionYellow laser photocoagulation is a safe, effective, minimally invasive outpatient treatment for conjunctival nevi, including deeply pigmented cases. It yields excellent cosmetic outcomes with minimal side effects, supporting its role as a potential standard of care.